ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson Breast Cancer Studies Promising NEJM Publishes Bonadnna Report

February 27, 1976

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

Cancer Letter On Vacation

August 3, 1984

NINDS Awards Grants For Brain Tumor Centers

December 11, 1992

UNC Oncologist Edison Liu To Direct NCI Intramural Clinical Research Programs

June 28, 1996